{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:21:58Z","timestamp":1787559718700,"version":"build-2736575974"},"reference-count":145,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Therapeutic glycoproteins, a pivotal class of biopharmaceuticals, have transformed modern medicine through their broad applications in oncology, immunotherapy, and infectious disease management. Their structural complexity and biological specificity make them highly effective in targeting disease pathways; however, challenges related to stability, bioavailability, and delivery efficacy limit their full potential. Recent advancements in delivery technologies have sought to address these challenges through innovative approaches such as nanotechnology-based carriers, controlled-release systems, and molecular engineering. These strategies have demonstrated the ability to enhance glycoprotein stability, optimize pharmacokinetics, and achieve targeted delivery with minimal off-target effects. This review provides a comprehensive overview of state-of-the-art lipid-based delivery systems specifically designed to overcome the unique pharmaceutical challenges associated with therapeutic glycoproteins, highlighting their design principles, formulation strategies, mechanisms of encapsulation and release, and therapeutic advantages in improving glycoprotein stability, bioavailability, targeted delivery, and treatment efficacy. In addition to surveying the current landscape, this review delves into the key challenges impeding the widespread adoption of advanced delivery systems, including immunogenicity, manufacturing scalability, and clinical translation. The review concludes with insights into emerging trends in the development of lipid-based delivery systems, positioning glycoprotein therapeutics at the forefront of innovation in biopharmaceuticals. This overview of advancements and challenges aims to provide a roadmap for future progress in the field of glycoprotein delivery and therapeutic applications.<\/jats:p>","DOI":"10.3390\/pharmaceutics18091045","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:03:41Z","timestamp":1787558621000},"page":"1045","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid-Based Delivery Systems for Therapeutic Glycoproteins: Current Advances, Challenges, and Future Perspectives"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0820-3884","authenticated-orcid":false,"given":"Hamad","family":"Alrbyawi","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Industries, College of Pharmacy, Taibah University, Al-Madinah Al-Munawarah 41477, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","article-title":"Global View of Human Protein Glycosylation Pathways and Functions","volume":"21","author":"Schjoldager","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1096\/fj.14-267096","article-title":"The Atypical N-glycosylation Motif, Asn-Cys-Cys, in Human GPR109A Is Required for Normal Cell Surface Expression and Intracellular Signaling","volume":"29","author":"Yasuda","year":"2015","journal-title":"FASEB J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1992068","DOI":"10.1080\/19420862.2021.1992068","article-title":"An Efficient System for Bioconjugation Based on a Widely Applicable Engineered O-Glycosylation Tag","volume":"13","author":"Murray","year":"2021","journal-title":"MAbs"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nbt1252","article-title":"Post-Translational Modifications in the Context of Therapeutic Proteins","volume":"24","author":"Walsh","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.sbi.2019.05.019","article-title":"V Relating Glycoprotein Structural Heterogeneity to Function\u2014Insights from Native Mass Spectrometry","volume":"58","author":"Struwe","year":"2019","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41392-024-01888-z","article-title":"Cell\u2013Cell Communication: New Insights and Clinical Implications","volume":"9","author":"Su","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Guerrero, G.G., Madrid-Marina, V., Mart\u00ednez-Romero, A., Torres-Poveda, K., and Favela-Hern\u00e1ndez, J.M. (2025). Host\u2013Pathogen Interaction Interface: Promising Candidate Targets for Vaccine-Induced Protective and Memory Immune Responses. Vaccines, 13.","DOI":"10.3390\/vaccines13040418"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Goettig, P. (2016). Effects of Glycosylation on the Enzymatic Activity and Mechanisms of Proteases. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17121969"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"13127","DOI":"10.1021\/acs.est.8b03180","article-title":"Identification of Glycoproteins Isolated from Extracellular Polymeric Substances of Full-Scale Anammox Granular Sludge","volume":"52","author":"Boleij","year":"2018","journal-title":"Environ. Sci. Technol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.bbagen.2016.03.012","article-title":"The Promise of Protein Glycosylation for Personalised Medicine","volume":"1860","author":"Almeida","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Gen. Subj."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5661\/bger-28-147","article-title":"Production Platforms for Biotherapeutic Glycoproteins. Occurrence, Impact, and Challenges of Non-Human Sialylation","volume":"28","author":"Ghaderi","year":"2012","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood-2011-02-336172","article-title":"Prolonged Half-Life and Preserved Enzymatic Properties of Factor IX Selectively PEGylated on Native N-Glycans in the Activation Peptide","volume":"118","author":"Bjelke","year":"2011","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e760","DOI":"10.1002\/mco2.760","article-title":"Clinical Glycoproteomics: Methods and Diseases","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101463","DOI":"10.1016\/j.omtm.2025.101463","article-title":"Lipid Nanoparticles: Composition, Formulation, and Application","volume":"33","author":"Xu","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zhang, X., Li, X., Zhao, Y., Zheng, Q., Wu, Q., and Yu, Y. (2022). Nanocarrier System: An Emerging Strategy for Bioactive Peptide Delivery. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.1050647"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2006.12.002","article-title":"Differential Tumor Cell Targeting of Anti-HER2 (Herceptin\u00ae) and Anti-CD20 (Mabthera\u00ae) Coupled Nanoparticles","volume":"331","author":"Cirstoiuhapca","year":"2007","journal-title":"Int. J. Pharm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2004433","DOI":"10.1002\/advs.202004433","article-title":"Cytokines: From Clinical Significance to Quantification","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Flores, D., Zepeda-Cervantes, J., Cruz-Res\u00e9ndiz, A., Aguirre-Sampieri, S., Sampieri, A., and Vaca, L. (2021). SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.701501"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/19768354.2022.2079719","article-title":"Mannose-6-Phosphate Glycan for Lysosomal Targeting: Various Applications from Enzyme Replacement Therapy to Lysosome-Targeting Chimeras","volume":"26","author":"Seo","year":"2022","journal-title":"Anim. Cells Syst."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.copbio.2019.01.014","article-title":"Chemical and Physical Instabilities in Manufacturing and Storage of Therapeutic Proteins","volume":"60","author":"Krause","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/jps.21504","article-title":"Effects of Glycosylation on the Stability of Protein Pharmaceuticals","volume":"98","author":"Griebenow","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Baral, K.C., and Choi, K.Y. (2025). Barriers and Strategies for Oral Peptide and Protein Therapeutics Delivery: Update on Clinical Advances. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17040397"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00726-019-02787-2","article-title":"Susceptibility of Protein Therapeutics to Spontaneous Chemical Modifications by Oxidation, Cyclization, and Elimination Reactions","volume":"51","author":"Grassi","year":"2019","journal-title":"Amino Acids"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1039\/D1CB00067E","article-title":"Aggregation of Protein Therapeutics Enhances Their Immunogenicity: Causes and Mitigation Strategies","volume":"2","author":"Lundahl","year":"2021","journal-title":"RSC Chem. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.xphs.2019.01.019","article-title":"Rapid Prediction of Deamidation Rates of Proteins to Assess Their Long-Term Stability Using Hydrogen Exchange\u2013Mass Spectrometry","volume":"108","author":"Gamage","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ejps.2007.10.008","article-title":"PH Dependent Effect of Glycosylation on Protein Stability","volume":"33","author":"Wang","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"108206","DOI":"10.1016\/j.biotechadv.2023.108206","article-title":"Glycosylation Shapes the Efficacy and Safety of Diverse Protein, Gene and Cell Therapies","volume":"67","author":"Rocamora","year":"2023","journal-title":"Biotechnol. Adv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12551-024-01188-4","article-title":"An Overview on Glycation: Molecular Mechanisms, Impact on Proteins, Pathogenesis, and Inhibition","volume":"16","author":"Uceda","year":"2024","journal-title":"Biophys. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Coghlan, J., Benet, A., Kumaran, P., Ford, M., Veale, L., Skilton, S.J., Saveliev, S., and Schwendeman, A.A. (2022). Streamlining the Characterization of Disulfide Bond Shuffling and Protein Degradation in IgG1 Biopharmaceuticals Under Native and Stressed Conditions. Front. Bioeng. Biotechnol., 10.","DOI":"10.3389\/fbioe.2022.862456"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/1547691X.2013.821564","article-title":"Immunogenicity of Therapeutic Proteins: Influence of Aggregation","volume":"11","author":"Ratanji","year":"2014","journal-title":"J. Immunotoxicol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"6342","DOI":"10.1016\/j.apsb.2025.10.026","article-title":"Progress in Peptide and Protein Therapeutics: Challenges and Strategies","volume":"15","author":"Liu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"103767","DOI":"10.1016\/j.drudis.2023.103767","article-title":"Lysosome and Related Protein Degradation Technologies","volume":"28","author":"Zheng","year":"2023","journal-title":"Drug Discov. Today"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Masson, P., and Lushchekina, S. (2022). Conformational Stability and Denaturation Processes of Proteins Investigated by Electrophoresis under Extreme Conditions. Molecules, 27.","DOI":"10.3390\/molecules27206861"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s41120-022-00067-0","article-title":"Glycopeptide Antibiotic Drug Stability in Aqueous Solution","volume":"8","author":"Jakaria","year":"2022","journal-title":"AAPS Open"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s11095-011-0451-4","article-title":"Oxidized and Aggregated Recombinant Human Interferon Beta Is Immunogenic in Human Interferon Beta Transgenic Mice","volume":"28","author":"Sauerborn","year":"2011","journal-title":"Pharm. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1208\/s12248-019-0312-3","article-title":"Interfacial Stress in the Development of Biologics: Fundamental Understanding, Current Practice, and Future Perspective","volume":"21","author":"Li","year":"2019","journal-title":"AAPS J."},{"key":"ref_37","first-page":"1","article-title":"The Effect of Shear Stress on Protein Conformation","volume":"153","year":"2010","journal-title":"Biophys. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"106850","DOI":"10.1016\/j.jddst.2025.106850","article-title":"Preservation of Extracellular Vesicles for Drug Delivery: A Comparative Evaluation of Storage Buffers","volume":"107","author":"Geng","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1080\/17460441.2021.1942837","article-title":"Recent Advances in Proteolytic Stability for Peptide, Protein, and Antibody Drug Discovery","volume":"16","author":"Lai","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Magnelli, P.E., Bielik, A.M., and Guthrie, E.P. (2011). Identification and Characterization of Protein Glycosylation Using Specific Endo- and Exoglycosidases. J. Vis. Exp., e3749.","DOI":"10.3791\/3749-v"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1093\/glycob\/cwi041","article-title":"Lysosomal Metabolism of Glycoproteins","volume":"15","author":"Winchester","year":"2005","journal-title":"Glycobiology"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Makharadze, D., del Valle, L.J., Katsarava, R., and Puiggal\u00ed, J. (2025). The Art of PEGylation: From Simple Polymer to Sophisticated Drug Delivery System. Int. J. Mol. Sci., 26.","DOI":"10.20944\/preprints202502.0191.v1"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1995929","DOI":"10.1080\/19420862.2021.1995929","article-title":"The Impact of Immunogenicity on Therapeutic Antibody Pharmacokinetics: A Preclinical Evaluation of the Effect of Immune Complex Formation and Antibody Effector Function on Clearance","volume":"13","author":"Jordan","year":"2021","journal-title":"MAbs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1365-2567.1996.d01-673.x","article-title":"Immunogenicity of Peptides for B Cells Is Not Impaired by Overlapping T-cell Epitope Topology","volume":"88","author":"Harris","year":"1996","journal-title":"Immunology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.copbio.2006.06.010","article-title":"Challenges in Therapeutic Glycoprotein Production","volume":"17","author":"Sethuraman","year":"2006","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"20029","DOI":"10.1038\/srep20029","article-title":"At Least Two Fc Neu5Gc Residues of Monoclonal Antibodies Are Required for Binding to Anti-Neu5Gc Antibody","volume":"6","author":"Yu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Paurevi\u0107, M., \u0160rajer Gajdo\u0161ik, M., and Ribi\u0107, R. (2024). Mannose Ligands for Mannose Receptor Targeting. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031370"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1016\/j.celrep.2020.02.111","article-title":"Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity","volume":"30","author":"Ols","year":"2020","journal-title":"Cell Rep."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Howard, E.L., Goens, M.M., Susta, L., Patel, A., and Wootton, S.K. (2025). Anti-Drug Antibody Response to Therapeutic Antibodies and Potential Mitigation Strategies. Biomedicines, 13.","DOI":"10.3390\/biomedicines13020299"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"La-Beck, N.M., Islam, M.R., and Markiewski, M.M. (2021). Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.603039"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.2147\/IJN.S82481","article-title":"Accelerated Blood Clearance Phenomenon upon Cross-Administration of PEGylated Nanocarriers in Beagle Dogs","volume":"10","author":"Deng","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ddr.21832","article-title":"Challenges of Peptide and Protein Drug Delivery by Oral Route: Current Strategies to Improve the Bioavailability","volume":"82","author":"Verma","year":"2021","journal-title":"Drug Dev. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbrc.2006.01.030","article-title":"Glycosylation in the Fc Domain of IgG Increases Resistance to Proteolytic Cleavage by Papain","volume":"341","author":"Raju","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2217\/nnm.11.11","article-title":"Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery Across The Blood\u2013Brain Barrier","volume":"6","author":"Tosi","year":"2011","journal-title":"Nanomedicine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s11248-010-9367-8","article-title":"Human Growth Hormone Expressed in Tobacco Cells as an Arabinogalactan-Protein Fusion Glycoprotein Has a Prolonged Serum Life","volume":"19","author":"Xu","year":"2010","journal-title":"Transgenic Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/bj2230151","article-title":"Uptake of Mannose-Terminated Glycoproteins in Isolated Rat Liver Cells. Evidence for Receptor-Mediated Endocytosis in Hepatocytes","volume":"223","author":"Tolleshaug","year":"1984","journal-title":"Biochem. J."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Wielgat, P., Rogowski, K., Niemirowicz-Laskowska, K., and Car, H. (2020). Sialic Acid-Siglec Axis as Molecular Checkpoints Targeting of Immune System: Smart Players in Pathology and Conventional Therapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124361"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s13238-017-0408-4","article-title":"Pharmacokinetics of Monoclonal Antibodies and Fc-Fusion Proteins","volume":"9","author":"Liu","year":"2018","journal-title":"Protein Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.copbio.2009.10.008","article-title":"Expression Systems for Therapeutic Glycoprotein Production","volume":"20","author":"Durocher","year":"2009","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00253-012-4451-z","article-title":"Recent Advances in Technology Supporting Biopharmaceutical Production from Mammalian Cells","volume":"96","author":"Butler","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Palladino, F., Marcelino, P.R.F., Schlogl, A.E., Jos\u00e9, \u00c1.H.M., Rodrigues, R.d.C.L.B., Fabrino, D.L., Santos, I.J.B., and Rosa, C.A. (2024). Bioreactors: Applications and Innovations for a Sustainable and Healthy Future\u2014A Critical Review. Appl. Sci., 14.","DOI":"10.3390\/app14209346"},{"key":"ref_62","first-page":"1","article-title":"Challenges and Solutions for the Downstream Purification of Therapeutic Proteins","volume":"7","author":"Tang","year":"2024","journal-title":"Antib. Ther."},{"key":"ref_63","first-page":"100399","article-title":"Advanced Microfluidic Techniques for the Preparation of Solid Lipid Nanoparticles: Innovations and Biomedical Applications","volume":"10","year":"2025","journal-title":"Int. J. Pharm. X"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Kim, E.J., Kim, J.H., Kim, M.-S., Jeong, S.H., and Choi, D.H. (2021). Process Analytical Technology Tools for Monitoring Pharmaceutical Unit Operations: A Control Strategy for Continuous Process Verification. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13060919"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"114904","DOI":"10.1016\/j.addr.2023.114904","article-title":"Strategies for Overcoming Protein and Peptide Instability in Biodegradable Drug Delivery Systems","volume":"199","author":"Shi","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Alshaer, W., Nsairat, H., Lafi, Z., Hourani, O.M., Al-Kadash, A., Esawi, E., and Alkilany, A.M. (2022). Quality by Design Approach in Liposomal Formulations: Robust Product Development. Molecules, 28.","DOI":"10.3390\/molecules28010010"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"121700","DOI":"10.1016\/j.ijpharm.2022.121700","article-title":"Impact of Critical Process Parameters and Critical Material Attributes on the Critical Quality Attributes of Liposomal Formulations Prepared Using Continuous Processing","volume":"619","author":"Yenduri","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Dob\u00f3, D.G., N\u00e9meth, Z., Sipos, B., Cseh, M., Pallagi, E., Berkesi, D., Kozma, G., K\u00f3nya, Z., and Cs\u00f3ka, I. (2022). Pharmaceutical Development and Design of Thermosensitive Liposomes Based on the QbD Approach. Molecules, 27.","DOI":"10.3390\/molecules27051536"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"8611","DOI":"10.2147\/IJN.S534137","article-title":"A Review on QbD-Driven Optimization of Lipid Nanoparticles for Oral Drug Delivery: From Framework to Formulation","volume":"20","author":"Hidayat","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s42247-021-00335-x","article-title":"Review on Metal Nanoparticles as Nanocarriers: Current Challenges and Perspectives in Drug Delivery Systems","volume":"5","author":"Chandrakala","year":"2022","journal-title":"Emergent Mater."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2174\/1389200217666160619191853","article-title":"Actively Targeted Nanoparticles for Drug Delivery to Tumor","volume":"17","author":"Bi","year":"2016","journal-title":"Curr. Drug Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"100083","DOI":"10.1016\/j.ntm.2025.100083","article-title":"Nanoparticles for Drug Delivery: Insight into in Vitro and in Vivo Drug Release from Nanomedicines","volume":"4","author":"Ewii","year":"2025","journal-title":"Nano TransMed"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e70337","DOI":"10.1002\/mco2.70337","article-title":"Nanocarrier-Based Systems for Targeted Delivery: Current Challenges and Future Directions","volume":"6","author":"Xu","year":"2025","journal-title":"MedComm"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.smim.2017.08.010","article-title":"Drug Nanocarriers to Treat Autoimmunity and Chronic Inflammatory Diseases","volume":"34","author":"Prosperi","year":"2017","journal-title":"Semin. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Wang, D.-Y., van der Mei, H.C., Ren, Y., Busscher, H.J., and Shi, L. (2020). Lipid-Based Antimicrobial Delivery-Systems for the Treatment of Bacterial Infections. Front. Chem., 7.","DOI":"10.3389\/fchem.2019.00872"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"114531","DOI":"10.1016\/j.addr.2022.114531","article-title":"Liposomal Formulations for Treating Lysosomal Storage Disorders","volume":"190","author":"Sala","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"30540","DOI":"10.1021\/acsnano.4c08922","article-title":"Glycopolymeric Nanoparticles Enrich Less Immunogenic Protein Coronas, Reduce Mononuclear Phagocyte Clearance, and Improve Tumor Delivery Compared to PEGylated Nanoparticles","volume":"18","author":"Hulugalla","year":"2024","journal-title":"ACS Nano"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Kim, M.W., Kwon, S.-H., Choi, J.H., and Lee, A. (2018). A Promising Biocompatible Platform: Lipid-Based and Bio-Inspired Smart Drug Delivery Systems for Cancer Therapy. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123859"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Gbian, D.L., and Omri, A. (2022). Lipid-Based Drug Delivery Systems for Diseases Managements. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092137"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1208\/s12249-025-03189-2","article-title":"Exploring Protein Aggregation in Biological Products: From Mechanistic Understanding to Practical Solutions","volume":"26","author":"Rojekar","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4155\/tde-2023-0048","article-title":"Nanoparticle-Based Delivery Platforms for the Enhanced Oral Delivery of Peptides\/Proteins","volume":"14","author":"Salatin","year":"2023","journal-title":"Ther. Deliv."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.2174\/0929867325666181101110050","article-title":"Nanocarriers: A Successful Tool to Increase Solubility, Stability and Optimise Bioefficacy of Natural Constituents","volume":"26","author":"Bilia","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/138920012798356934","article-title":"PEGylation of Proteins and Liposomes: A Powerful and Flexible Strategy to Improve the Drug Delivery","volume":"13","author":"Milla","year":"2012","journal-title":"Curr. Drug Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jddst.2015.09.004","article-title":"Recent Studies on the Delivery of Hydrophilic Drugs in Nanoparticulate Systems","volume":"32","author":"Arpicco","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Fu, S., Zhu, X., Huang, F., and Chen, X. (2025). Anti-PEG Antibodies and Their Biological Impact on PEGylated Drugs: Challenges and Strategies for Optimization. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17081074"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1208\/s12249-025-03226-0","article-title":"A Comparative Study of the Influence of Lipid Composition on Stability, In Vitro Release, and Antioxidant Activity of Quercetin-Loaded Ceramide-Containing Liposomes for Topical Delivery","volume":"26","author":"Tsichlis","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2500485","DOI":"10.1002\/adhm.202500485","article-title":"Membrane Fusion-Inspired Nanomaterials: Emerging Strategies for Infectious Disease and Cancer Diagnostics","volume":"15","author":"Lee","year":"2026","journal-title":"Adv. Healthc. Mater."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijpharm.2014.07.020","article-title":"The Influence of Phospholipid on the Physicochemical Properties and Anti-Tumor Efficacy of Liposomes Encapsulating Cisplatin in Mice Bearing C26 Colon Carcinoma","volume":"473","author":"Alavizadeh","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ymthe.2004.12.018","article-title":"Nonbilayer Phase of Lipoplex\u2013Membrane Mixture Determines Endosomal Escape of Genetic Cargo and Transfection Efficiency","volume":"11","author":"Zuhorn","year":"2005","journal-title":"Mol. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Pavlovic, N., Mijalkovi\u0107, J., Balan\u010d, B., Lukovi\u0107, N., and Kne\u017eevi\u0107-Jugovi\u0107, Z. (2025). Role of Cholesterol in Modifying the Physical and Stability Properties of Liposomes and In Vitro Release of VitaminB12. Eng. Proc., 99.","DOI":"10.3390\/engproc2025099010"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"126447","DOI":"10.1016\/j.colsurfa.2021.126447","article-title":"Sphingomyelin-Based Liposomes with Different Cholesterol Contents and Polydopamine Coating as a Controlled Delivery System","volume":"618","author":"Lim","year":"2021","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2023.09.003","article-title":"Accelerated Blood Clearance of PEGylated Nanoparticles Induced by PEG-Based Pharmaceutical Excipients","volume":"363","author":"Miao","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Kim, Y., Park, J., Choi, J., Kim, M., Seo, G., Kim, J., Park, J.-A., Lim, K.S., Ha, S.-J., and Kim, H.-O. (2025). Physiological Barriers to Nucleic Acid Therapeutics and Engineering Strategies for Lipid Nanoparticle Design, Optimization, and Clinical Translation. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17101309"},{"key":"ref_94","first-page":"9","article-title":"Ionizable Drug Delivery Systems for Efficient and Selective Gene Therapy","volume":"10","author":"Zhang","year":"2023","journal-title":"Mil. Med. Res."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Yan, S., Na, J., Liu, X., and Wu, P. (2024). Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16020248"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/s41467-023-37465-1","article-title":"GalNAc-Lipid Nanoparticles Enable Non-LDLR Dependent Hepatic Delivery of a CRISPR Base Editing Therapy","volume":"14","author":"Kasiewicz","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in Cancer Therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Pisani, S., Di Martino, D., Cerri, S., Genta, I., Dorati, R., Bertino, G., Benazzo, M., and Conti, B. (2023). Investigation and Comparison of Active and Passive Encapsulation Methods for Loading Proteins into Liposomes. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713542"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Sobol, \u017b., Chiczewski, R., and W\u0105tr\u00f3bska-\u015awietlikowska, D. (2025). Advances in Liposomal Drug Delivery: Multidirectional Perspectives on Overcoming Biological Barriers. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17070885"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Liu, P., Chen, G., and Zhang, J. (2022). A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives. Molecules, 27.","DOI":"10.3390\/molecules27041372"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Sercombe, L., Veerati, T., Moheimani, F., Wu, S.Y., Sood, A.K., and Hua, S. (2015). Advances and Challenges of Liposome Assisted Drug Delivery. Front. Pharmacol., 6.","DOI":"10.3389\/fphar.2015.00286"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e13823","DOI":"10.1016\/j.heliyon.2023.e13823","article-title":"PEGylated Liposomes Enhance the Effect of Cytotoxic Drug: A Review","volume":"9","author":"Taher","year":"2023","journal-title":"Heliyon"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e1450","DOI":"10.1002\/wnan.1450","article-title":"Stimuli-responsive Liposomes for Drug Delivery","volume":"9","author":"Lee","year":"2017","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Tsirogianni, A.G., Chountoulesi, M., and Pippa, N. (2025). Recent Advances in PH-Responsive Liposomes: Lessons Learnt and New Directions in Nanomedicine Development. Materials, 18.","DOI":"10.3390\/ma18184295"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.2147\/IJN.S49297","article-title":"Thermosensitive Liposomal Drug Delivery Systems: State of the Art Review","volume":"9","author":"Hossann","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Abed, H.F., Abuwatfa, W.H., and Husseini, G.A. (2022). Redox-Responsive Drug Delivery Systems: A Chemical Perspective. Nanomaterials, 12.","DOI":"10.3390\/nano12183183"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"104014","DOI":"10.1016\/j.drudis.2024.104014","article-title":"Enzyme-Responsive Liposomes for Controlled Drug Release","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3109\/09687688.2010.507788","article-title":"Light-Sensitive Lipid-Based Nanoparticles for Drug Delivery: Design Principles and Future Considerations for Biological Applications","volume":"27","author":"Yavlovich","year":"2010","journal-title":"Mol. Membr. Biol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"124355","DOI":"10.1016\/j.ijpharm.2024.124355","article-title":"Laronidase-Loaded Liposomes Reach the Brain and Other Hard-to-Treat Organs after Noninvasive Nasal Administration","volume":"660","author":"Schuh","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1021\/acs.molpharmaceut.2c00086","article-title":"Optimization of a Liposomal DNase I Formulation with an Extended Circulating Half-Life","volume":"19","author":"Huynh","year":"2022","journal-title":"Mol. Pharm."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/bjophthalmol-2016-310044","article-title":"Treatment of Experimental Autoimmune Uveoretinitis with Intravitreal Injection of Infliximab Encapsulated in Liposomes","volume":"101","author":"Zhang","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00002371-199705000-00003","article-title":"Delivery of Cytokines by Liposomes. III. Liposome- Encapsulated GM-CSF and TNF-?? Show Improved Pharmacokinetics and Biological Activity and Reduced Toxicity in Mice","volume":"20","author":"Kedar","year":"1997","journal-title":"J. Immunother."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2015.05.271","article-title":"Cetuximab-Oxaliplatin-Liposomes for Epidermal Growth Factor Receptor Targeted Chemotherapy of Colorectal Cancer","volume":"210","author":"Zalba","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1039\/C8MD00515J","article-title":"Diversity of PEGylation Methods of Liposomes and Their Influence on RNA Delivery","volume":"10","author":"Nosova","year":"2019","journal-title":"Medchemcomm"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.actbio.2025.02.035","article-title":"Subcutaneous Liposomal Delivery Improves Monoclonal Antibody Pharmacokinetics in Vivo","volume":"195","author":"Karimi","year":"2025","journal-title":"Acta Biomater."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.drudis.2021.05.010","article-title":"Stimulus-Responsive Liposomes for Biomedical Applications","volume":"26","author":"Antoniou","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1021\/acs.molpharmaceut.5b00260","article-title":"Light-Controlled Delivery of Monoclonal Antibodies for Targeted Photoinactivation of Ki-67","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Pharm."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1021\/mp500453a","article-title":"Therapeutic Impact of Erythropoietin-Encapsulated Liposomes Targeted to Bone Marrow on Renal Anemia","volume":"11","author":"Miyazaki","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2022.11.032","article-title":"Insulin-Loaded Liposomes Packaged in Alginate Hydrogels Promote the Oral Bioavailability of Insulin","volume":"353","author":"Wu","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Gatto, M.S., Johnson, M.P., and Najahi-Missaoui, W. (2024). Targeted Liposomal Drug Delivery: Overview of the Current Applications and Challenges. Life, 14.","DOI":"10.3390\/life14060672"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"111203","DOI":"10.1016\/j.colsurfb.2020.111203","article-title":"Folate Targeted PEGylated Liposomes for the Oral Delivery of Insulin: In Vitro and in Vivo Studies","volume":"194","author":"Yazdi","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-Based Nanoparticles for Drug\/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Mater. Au"},{"key":"ref_123","first-page":"17","article-title":"A Recent Update: Solid Lipid Nanoparticles for Effective Drug Delivery","volume":"12","author":"Pandey","year":"2021","journal-title":"Adv. Pharm. Bull."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Subroto, E., Andoyo, R., and Indiarto, R. (2023). Solid Lipid Nanoparticles: Review of the Current Research on Encapsulation and Delivery Systems for Active and Antioxidant Compounds. Antioxidants, 12.","DOI":"10.3390\/antiox12030633"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Jadon, R.S., Jadon, P.S., Bhadauria, V., Sharma, V., Bharadwaj, S., Sharma, M., Gajbhiye, K.R., and Gajbhiye, V. (2022). Solid\u2013Lipid Nanoparticles Based Vehicles for Stimuli Inspired Delivery of Bioactives. Stimuli-Responsive Nanocarriers, Elsevier.","DOI":"10.1016\/B978-0-12-824456-2.00001-1"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40005-022-00573-z","article-title":"Smart PH-Responsive Nanomedicines for Disease Therapy","volume":"52","author":"Shinn","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijpharm.2018.08.010","article-title":"Redox Sensitive Lipid-Camptothecin Conjugate Encapsulated Solid Lipid Nanoparticles for Oral Delivery","volume":"549","author":"Du","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1021\/nl2036047","article-title":"Remotely Activated Protein-Producing Nanoparticles","volume":"12","author":"Schroeder","year":"2012","journal-title":"Nano Lett."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1021\/acsami.8b00507","article-title":"Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin","volume":"10","author":"Xu","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.colsurfb.2017.07.080","article-title":"Topical Co-Delivery of Methotrexate and Etanercept Using Lipid Nanoparticles: A Targeted Approach for Psoriasis Management","volume":"159","author":"Ferreira","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Haider, M., Abdin, S.M., Kamal, L., and Orive, G. (2020). Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12030288"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jsps.2021.07.015","article-title":"Nanostructured Lipid Carriers (NLCs) as Drug Delivery Platform: Advances in Formulation and Delivery Strategies","volume":"29","author":"Elmowafy","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"150","DOI":"10.34172\/apb.2020.021","article-title":"Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery","volume":"10","author":"Chauhan","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/21691401.2017.1296847","article-title":"Targeted Delivery of Doxorubicin into Tumor Cells by Nanostructured Lipid Carriers Conjugated to Anti-EGFRvIII Monoclonal Antibody","volume":"46","author":"Abdolahpour","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1021\/mp200402e","article-title":"Tumor Specific Delivery and Therapy by Double-Targeted Nanostructured Lipid Carriers with Anti-VEGFR-2 Antibody","volume":"8","author":"Liu","year":"2011","journal-title":"Mol. Pharm."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2147\/DDDT.S123939","article-title":"Development of Erythropoietin Receptor-Targeted Drug Delivery System against Breast Cancer Using Tamoxifen-Loaded Nanostructured Lipid Carriers","volume":"11","author":"Beh","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Shahzadi, I., F\u00fcrst, A., Knoll, P., and Bernkop-Schn\u00fcrch, A. (2021). Nanostructured Lipid Carriers (NLCs) for Oral Peptide Drug Delivery: About the Impact of Surface Decoration. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13081312"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1073\/pnas.0931428100","article-title":"Immunomicelles: Targeted Pharmaceutical Carriers for Poorly Soluble Drugs","volume":"100","author":"Torchilin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Negut, I., and Bita, B. (2023). Polymeric Micellar Systems\u2014A Special Emphasis on \u201cSmart\u201d Drug Delivery. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15030976"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0168-3659(03)00217-7","article-title":"Micelles from Polyethylene Glycol\/Phosphatidylethanolamine Conjugates for Tumor Drug Delivery","volume":"91","author":"Lukyanov","year":"2003","journal-title":"J. Control. Release"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s13346-024-01562-5","article-title":"Evaluation of MAb 2C5-Modified Dendrimer-Based Micelles for the Co-Delivery of SiRNA and Chemotherapeutic Drug in Xenograft Mice Model","volume":"14","author":"Yalamarty","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2019.12.002","article-title":"Dual Stimuli-Guided Lipid-Based Delivery System of Cancer Combination Therapy","volume":"318","author":"Liu","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"114281","DOI":"10.1016\/j.ejmech.2022.114281","article-title":"PH-Redox Responsive Cascade-Targeted Liposomes to Intelligently Deliver Doxorubicin Prodrugs and Lonidamine for Glioma","volume":"235","author":"Zhao","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Ribeiro, B.C., Alvarez, C.A.R., Alves, B.C., Rodrigues, J.M., Queiroz, M.J.R.P., Almeida, B.G., Pires, A., Pereira, A.M., Ara\u00fajo, J.P., and Coutinho, P.J.G. (2022). Development of Thermo- and PH-Sensitive Liposomal Magnetic Carriers for New Potential Antitumor Thienopyridine Derivatives. Materials, 15.","DOI":"10.3390\/ma15051737"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Liu, G., He, S., Ding, Y., Chen, C., Cai, Q., and Zhou, W. (2021). Multivesicular Liposomes for Glucose-Responsive Insulin Delivery. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010021"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1045\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:04:29Z","timestamp":1787558669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/9\/1045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":145,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["pharmaceutics18091045"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18091045","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]}}}